سعر ايثيرونيت 400 مجم / 5 مل معلق 100 مل 2022

Ethyronate (erythromycin) 400 mg/5 ml oral suspension, 100 ml, by Unipharma (Egypt); macrolide antibiotic.

• Infections caused by susceptible strains of the designated organisms, including mild-to-moderate upper and lower respiratory tract infections (Streptococcus pyogenes, S. pneumoniae; H. influenzae with a sulfonamide), listeriosis, pertussis, Mycoplasma pneumoniae respiratory infections and mild-to-moderate skin and skin-structure infections, among others listed in the US label.Population: Children and adultsDailyMed (U.S. National Library of Medicine)

• Most frequent: gastrointestinal (abdominal pain, nausea, vomiting, diarrhoea, anorexia); also hepatitis, pseudomembranous colitis and allergic reactions.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to erythromycin; co-administration with terfenadine, astemizole, pimozide or cisapride; with HMG-CoA reductase inhibitors extensively metabolised by CYP3A4 (lovastatin, simvastatin).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hepatic dysfunction with or without jaundice has been reported; QT prolongation and torsades de pointes; Clostridioides difficile-associated diarrhoea.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• No evidence of teratogenicity in animal studies; no adequate and well-controlled studies in pregnant women; use in pregnancy only if clearly needed.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Erythromycin is excreted in human milk; use caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.